Quent Capital, LLC

Position in INCY — Incyte Corp

CIK 1912338 NEW YORK, NY

Position in INCY

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$37,271

+$1,023 QoQ

Shares Held

396

+7.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Quent Capital, LLC holds $1,203,336 across 36 Biotechnology names. INCY ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	366	$282,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	563	$251,402
3	ROIV	Roivant Sciences Ltd.	4,130	$114,401
4	INSM	INSMED Inc	616	$100,728
5	MRVI	Maravai Lifesciences Holdings, Inc.	30,000	$84,900
6	JAZZ	Jazz Pharmaceuticals plc	307	$58,038
7	INCY	Incyte Corp This page	396	$37,271
8	ALNY	Alnylam Pharmaceuticals, Inc.	67	$22,168

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,271	396	+7.9%	Shares	Sole	2026-04-28
2025-12-31	$36,248	367	+3.7%	Shares	Sole	2026-01-29
2025-09-30	$30,022	354	+205.2%	Shares	Sole	2025-10-27
2025-03-31	$7,023	116	+36.5%	Shares	Sole	2025-04-04
2024-12-31	$5,870	85	+4.9%	Shares	Sole	2025-01-29
2024-09-30	$5,354	81	+12.5%	Shares	Sole	2024-10-04
2024-06-30	$4,364	72	+84.6%	Shares	Sole	2024-07-08
2024-03-31	$2,221	39	-29.1%	Shares	Sole	2024-06-28
2023-12-31	$3,453	55	+400.0%	Shares	Sole	2024-06-17
2023-09-30	$635	11	0.0%	Shares	Sole	2024-06-17
2023-06-30	$684	11	-71.8%	Shares	Sole	2024-06-17
2023-03-31	$2,818	39	0.0%	Shares	Sole	2024-06-17
2022-12-31	$3,132	39	0.0%	Shares	Sole	2023-01-19
2022-09-30	$2,598	39	0.0%	Shares	Sole	2022-11-10
2022-06-30	$2,962	39	+18.2%	Shares	Sole	2022-08-08
2022-03-31	$2,620	33	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.